Exabis Library
Welcome to the e-CCO Library!
P0595: Comparative effectiveness between ustekinumab and vedolizumab after anti-TNF failure in Ulcerative Colitis: Real-world experience
2025
ECCO'25
Monday, 10 February 2025, 2:00 PM
P0596: Fecal bile acids predict the therapeutic effect of biological agents in patients with ulcerative colitis
2025
ECCO'25
Monday, 10 February 2025, 2:00 PM
P0597: Clinical and biochemical correlates of infliximab pharmacokinetics in adult patients with Inflammatory Bowel Disease
2025
ECCO'25
Monday, 10 February 2025, 2:00 PM
P0598: Feasibility and limitations in adopting treat-to-target approach in inflammatory bowel diseases (IBD): real-life scenario
2025
ECCO'25
Monday, 10 February 2025, 2:00 PM
P0599: Efficacy and safety of intravenous methylprednisolone and hydrocortisone in Acute Severe Ulcerative Colitis (ASUC) – a posthoc analysis of the IASO trial
2025
ECCO'25
Monday, 10 February 2025, 2:00 PM
P059: Diet controls segmented filamentous bacteria in driving Crohn’s disease-like inflammation in TNFdeltaARE mice
2022
ECCO'22
Friday, 11 February 2022, 3:52 PM
P059: GB004 drives protective effects on immune cells and epithelial cells using human ex vivo monolayer and co-culture systems
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P059: Klebicin as a novel therapy for Klebsiella infection management
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 10:48 AM
P059: Mucosal inflammation promotes activation of circulating Vδ2+ T-cells in Crohn's disease
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P059: Test of stability in stool extracts for F-calprotectin
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P059: The metformin inhibits MDSC and M2 macrophage via AMPK-induced inhibition of HMG-CoA reductase in tumour microenvironment of colitic cancer
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P059: Two new genetic mouse models for ulcerative colitis based on lateral tight junction disruption.
2016
ECCO '16 Amsterdam
Friday, 22 February 2019, 9:49 AM
P060 The pharmacologic inhibition of store-operated calcium entry pathway in inflammatory bowel disease
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P0600: Do GI Quant small bowel motility values correlate with reported MR enterography findings in Crohn's disease?
2025
ECCO'25
Monday, 10 February 2025, 2:00 PM
P0601: Is advanced combination therapy effective in patients with refractory Inflammatory Bowel Disease?
2025
ECCO'25
Monday, 10 February 2025, 2:00 PM
P0602: Long-term effectiveness and safety of ustekinumab dose escalation in patients with refractory ulcerative colitis: a multicenter retrospective cohort study
2025
ECCO'25
Monday, 10 February 2025, 2:00 PM
P0603: The real-world use of intravenous and subcutaneous Vedolizumab in IBD across Australia and New Zealandx7x7x7 Crohn’s Colitis Cure Data Insight’s Program.
2025
ECCO'25
Monday, 10 February 2025, 2:00 PM
P0604: Frequency and Analysis of Deep Remission in Patients with Ulcerative Colitis: A Single-Center Retrospective Study
2025
ECCO'25
Monday, 10 February 2025, 2:00 PM
P0605: Nutritional Therapy for IBD: a new non-profit organization that offers trustedx7x7x7 evidence-based information and novel resources on diet and nutritional therapies in IBD
2025
ECCO'25
Monday, 10 February 2025, 2:00 PM
P0606: The efficacy of upadacitinib in Intestinal Behçet's Disease refractory to anti-TNF-α therapy in a retrospective study
2025
ECCO'25
Monday, 10 February 2025, 2:00 PM